Chemical Compound

SGC-CBP30

CAS Registry Number 1613695-14-9
SGC-CBP30 chemical structure
Primary Record

SGC-CBP30

In stock
5,307 g
Purity
99.5 %
CAS
1613695-14-9

Compound Identifiers & Properties

CAS
1613695-14-9
PubChem CID
72201027
SMILES
CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)C[C@H](C)N5CCOCC5
Canonical SMILES
COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl

Names & Synonyms

  • SGC-CBP30
  • 1613695-14-9
  • CBP30 compound
  • SGCCBP30
  • RefChem:182668
  • CBP30
  • C28H33ClN4O3
  • D03XXT
  • SGC?CBP30
  • SGC-CBP-30
  • MFCD26792586
  • CBP-30
  • GTPL7529
  • orb1300573
  • CHEMBL3622373
  • SCHEMBL17512896
  • SCHEMBL29403969
  • AOB4800
  • BDBM188519
  • GLXC-03977
  • (s)-4-(1-(2-(3-chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1h-benzo[d]imidazol-1-yl)propan-2-yl)morpholine
  • EX-A2159
  • NPC69514
  • 2715AH
  • s7256
  • ZINC96170456
  • AKOS024458401
  • CCG-269770
  • CS-2096
  • NCGC00351475-07
  • SGC-CBP30, >=98% (HPLC)
  • [d]imidazol-1-yl)propan-2-yl)morpholine
  • AC-35767
  • AS-56079
  • BC600338
  • BP-25374
  • CID:72201027
  • HY-15826
  • SID:441325568
  • A4491
  • SW219645-1
  • J3.313.777J
  • A13227
  • C14984
  • A902266
  • 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole
  • BRD-K24821794-001-01-4
  • Q27088793
  • C000603860
  • 2-[2-(3-Chloro-4-Methoxyphenyl)ethyl]-5-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-1-[(2s)-2-(Morpholin-4-Yl)propyl]-1h-Benzimidazole
  • 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxaZol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benZodiaZole
  • 4-[(2S)-1-[2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzimidazol-1-yl]propan-2-yl]morpholine
  • (S)-4-(1-(2-(3-chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1H-benzo
  • 1-((S)-2-(4-Morpholinyl)propyl)-2-(2-(3-chloro-4-methoxyphenyl)ethyl)-5-(3,5-dimethylisoxazole-4-yl)-1H-benzoimidazole
  • 1-[(S)-2-Morpholinopropyl]-2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethylisoxazole-4-yl)-1H-benzoimidazole
  • 2-(2-(3-chloro-4-methoxyphenyl)ethyl)-5-(dimethyl-1,2-oxazol-4-yl)-1-((2S)-2-(morpholin-4-yl)propyl)-1H-1,3-benzodiazole
  • 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole
  • 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole; CBP 30; SGC-CBP 30
  • 2LO
  • 4-[(1S)-2-[2-[2-(3-chloro-4-methoxy-phenyl)ethyl]-5-(3,5-dimethylisoxazol-4-yl)benzimidazol-1-yl]-1-methyl-ethyl]morpholine
  • 5-(3,5-Dimethylisoxazole-4-yl)-2-[2-(3-chloro-4-methoxyphenyl)ethyl]-1-[(S)-2-morpholinopropyl]-1H-benzoimidazole